Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Halozyme Therapeutics, Inc. News

Biotechs Weakened by The Stock Market Rout

Biotechs continue to decline like tech stocks but the sector is adequately capitalized, analysts say.

Who Will Survive?: Cramer's 'Mad Money' Recap (Thursday 5/14/20)

Jim Cramer says many companies aren't prepared for extended shutdowns and they may not be able to get the credit they need to survive.

It's Bad, But It's Not a Crash: Cramer's 'Mad Money' Recap

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

Roku, Sierra Wireless, Visa, Cimarex Energy: 'Mad Money' Lightning Round

Jim Cramer focuses on Roku, Sierra Wireless, Visa, Cimarex Energy, First Solar, Halozyme Therapeutics.

Breaking News

The Good Times Are Over for Startups

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.